Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Human Papillomavirus / Human Papillomavirus Infection (HPV Infection) Vaccination, there are three licensed HPV vaccines: the bivalent vaccine (Cervarix, GSK, Rixensart, Belgium), the quadrivalent vaccine (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)), and the nonavalent vaccine (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)) (1).
In comparing the effectiveness of bivalent, quadrivalent, and nonavalent vaccines against HPV types 16 and 18, it has been found that their efficacy is quite similar. However, the nonavalent vaccine offers additional protection against HPV types 31, 33, 45, 52, and 58. Observations in real-world scenarios indicate a significant reduction in HPV…